HC Wainwright & Co. analyst Robert Burns downgrades TCR2 Therapeutics (NASDAQ:TCRR) from Buy to Neutral.
Taboola Reaffirms Q1 Guidance Ahead Of Investor Day Tuesday, Will Start At 8:30 a.m. EDT
Today, Taboola (NASDAQ:TBLA), a global leader in powering recommendations for the open web, helping people discover things they may like, is hosting its first investor day as a public company today at 8:30 a.m. ET in New